ERSOT
REGN icon

Employees Retirement System of Texas’s Regeneron Pharmaceuticals REGN Stock Holding History

Employees Retirement System of Texas’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Hold
1,324
– – 0.01% 220
2025
Q4 		$1.02M Hold
1,324
– – 0.01% 246
2025
Q3 		$744K Buy
+1,324
New +$749K 0.01% 250
2022
Q3 		– Sell
-15,800
Closed -$9.34M – 611
2022
Q2 		$9.34M Hold
15,800
– – 0.13% 193
2022
Q1 		$11M Hold
15,800
– – 0.13% 184
2021
Q4 		$9.98M Hold
15,800
– – 0.11% 213
2021
Q3 		$9.56M Sell
15,800
-1,355
-8% -$841K 0.11% 216
2021
Q2 		$9.58M Sell
17,155
-4,600
-21% -$2.33M 0.12% 211
2021
Q1 		$10.3M Sell
21,755
-1,000
-4% -$487K 0.13% 200
2020
Q4 		$11M Hold
22,755
– – 0.17% 149
2020
Q3 		$12.7M Buy
22,755
+6,000
+36% +$3.64M 0.19% 142
2020
Q2 		$10.4M Sell
16,755
-2,000
-11% -$1.14M 0.16% 157
2020
Q1 		$9.16M Buy
18,755
+8,955
+91% +$3.69M 0.17% 137
2019
Q4 		$3.68M Hold
9,800
– – 0.06% 352
2019
Q3 		$2.72M Sell
9,800
-6,700
-41% -$1.98M 0.04% 409
2019
Q2 		$5.17M Sell
16,500
-9,000
-35% -$3M 0.08% 289
2019
Q1 		$10.5M Buy
25,500
+4,000
+19% +$1.65M 0.16% 156
2018
Q4 		$8.03M Buy
21,500
+18,000
+514% +$6.59M 0.13% 179
2018
Q3 		$1.41M Sell
3,500
-8,500
-71% -$3.23M 0.02% 745
2018
Q2 		$4.14M Sell
12,000
-9,000
-43% -$2.81M 0.06% 410
2018
Q1 		$7.23M Buy
21,000
+8,000
+62% +$2.78M 0.1% 250
2017
Q4 		$4.89M Hold
13,000
– – 0.06% 381
2017
Q3 		$5.81M Hold
13,000
– – 0.08% 320
2017
Q2 		$6.38M Buy
13,000
+9,000
+225% +$3.94M 0.09% 304
2017
Q1 		$1.55M Hold
4,000
– – 0.02% 712
2016
Q4 		$1.47M Sell
4,000
-1,000
-20% -$380K 0.02% 728
2016
Q3 		$2.01M Hold
5,000
– – 0.03% 606
2016
Q2 		$1.75M Sell
5,000
-200
-4% -$77K 0.02% 620
2016
Q1 		$1.87M Sell
5,200
-9,000
-63% -$3.71M 0.03% 591
2015
Q4 		$7.71M Hold
14,200
– – 0.11% 217
2015
Q3 		$6.61M Sell
14,200
-2,000
-12% -$1.07M 0.09% 241
2015
Q2 		$8.26M Hold
16,200
– – 0.11% 204
2015
Q1 		$7.31M Buy
16,200
+1,000
+7% +$424K 0.09% 249
2014
Q4 		$6.24M Sell
15,200
-9,000
-37% -$3.54M 0.08% 295
2014
Q3 		$8.72M Buy
24,200
+8,255
+52% +$2.77M 0.11% 205
2014
Q2 		$4.5M Buy
15,945
+7,245
+83% +$2.15M 0.06% 384
2014
Q1 		$2.61M Sell
8,700
-3,400
-28% -$1.05M 0.03% 516
2013
Q4 		$3.33M Buy
12,100
+4,100
+51% +$1.18M 0.04% 457
2013
Q3 		$2.5M Sell
8,000
-11,000
-58% -$2.89M 0.03% 539
2013
Q2 		$4.27M Buy
+19,000
New +$4.42M 0.05% 359

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Employees Retirement System of Texas's REGN Position: Q1 2026 in Review

Employees Retirement System of Texas held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 1,324 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #220.

Employees Retirement System of Texas first reported a position in REGN in Q2 2013 and has held it in 40 quarters since. The position peaked at $12.7M in Q3 2020. 1,396 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Employees Retirement System of Texas held 1,324 shares of Regeneron Pharmaceuticals worth $1.02M as of Q1 2026.
  • Employees Retirement System of Texas left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.01% of Employees Retirement System of Texas's portfolio in Q1 2026, its #220 holding.
  • Employees Retirement System of Texas first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 40 quarters since.
  • Employees Retirement System of Texas's Regeneron Pharmaceuticals position peaked at $12.7M in Q3 2020.
  • 1,396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Employees Retirement System of Texas's 13F filing for Q1 2026, filed 13 May 2026.